Perlara YC Başvurusu

Winter 2016Active

Perlara, Healthcare şirketi olarak Winter 2016 grubunda Y Combinator'dan geçti. Aşağıda: şirketin ne yaptığı, kimin kurduğu ve gerçek YC formunda yeniden yapılandırılmış YC başvurusu.

YC grubu: Winter 2016
Sektör: HealthcareDrug Discovery and Delivery
Ekip büyüklüğü: 1
Durum: Active
Lansmanı Yapıldı: 2016

Perlara ne yapar

Perlara 1.0 (Feb 2014 - Feb 2019) launched early R&D joint ventures called PerlQuests with highly motivated rare disease families, companies or impact investors. We screened gene-edited patient avatars for repurposable drugs in order to build a predictive R&D engine called ArkBase. We planned to monetize programs based on ArkBase predictions by selectively spinning out asset-centric clinical development NewCos. Perlara 1.5 (March 2019 - April 2020) was the transition to a one-person virtual clinical development company and when the epalrestat and aripiprazole repurposing trials were launched at Mayo Clinic for the treatment of PMM2-CDG and NGLY1-CDDG, respectively. Perlara 2.0 (May 2020 --> The first decentralized and distributed biotech

Perlara'in YC başvurusu, yeniden yapılandırılmış

Y Combinator başvurusu

Perlara, Winter 2016 dönemi. Gerçek form soruları, herkese açık verilerden yanıtlandı.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Perlara

Describe what your company does in 50 characters or less.

Building the YC for rare disease parents

What is your company going to make? Please describe your product and what it does or will do.

We build a predictive R&D engine called ArkBase that uses gene-edited patient avatars to find repurposed drugs for rare diseases. We partner directly with rare disease families and clinics to launch clinical trials and spin out companies based on our experimental data.

Where do you live now, and where would the company be based after YC?

We're based in Oakland, CA, but operate remotely; the company remains distributed with virtual clinical development focus.

Explain your decision regarding location.

We chose Oakland as a base for proximity to Bay Area biotech and healthcare resources but maintain a distributed setup to stay close to patients and rare disease families worldwide.

Tam başvuruda 21 ek cevap

Founders, Progress, Idea, Equity, Curious, Batch Preference tam sürümde. YC Insights'ta, diğer her YC grubu yanında açmak için ücretsiz bir hesap oluşturun.

Tüm başvuruyu gör

Sıkça Sorulan Sorular

Bu, Perlara şirketinin gerçek YC başvurusu mu?

Hayır. Y Combinator gönderilen başvuruları gizli tutar. Bu bir yeniden yapılandırmadır: gerçek YC form soruları, Perlara'in kamuya açık verilerinden (lansman notları, kurucu geçmişleri, ürün açıklaması) yanıtlanmıştır. Perlara gibi bir şirketin YC'ye kendisini nasıl sunacağını gösterir, gönderdikleri metni değil.